[go: up one dir, main page]

IL106591A0 - An interferon alpha/beta binding protein,its preparation and pharmaceutical compositions containing it - Google Patents

An interferon alpha/beta binding protein,its preparation and pharmaceutical compositions containing it

Info

Publication number
IL106591A0
IL106591A0 IL106591A IL10659193A IL106591A0 IL 106591 A0 IL106591 A0 IL 106591A0 IL 106591 A IL106591 A IL 106591A IL 10659193 A IL10659193 A IL 10659193A IL 106591 A0 IL106591 A0 IL 106591A0
Authority
IL
Israel
Prior art keywords
preparation
pharmaceutical compositions
binding protein
compositions containing
interferon alpha
Prior art date
Application number
IL106591A
Other versions
IL106591A (en
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL103052A external-priority patent/IL103052A/en
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Priority to IL106591A priority Critical patent/IL106591A/en
Priority to AU46096/93A priority patent/AU674523B2/en
Priority to EP93114084A priority patent/EP0588177B1/en
Priority to CA2105449A priority patent/CA2105449C/en
Priority to ES93114084T priority patent/ES2142840T3/en
Priority to DE69327693T priority patent/DE69327693T2/en
Priority to JP24398793A priority patent/JP3662264B2/en
Priority to DK93114084T priority patent/DK0588177T3/en
Priority to AT93114084T priority patent/ATE189262T1/en
Priority to PT93114084T priority patent/PT588177E/en
Publication of IL106591A0 publication Critical patent/IL106591A0/en
Priority to US08/385,191 priority patent/US5821078A/en
Priority to US08/472,402 priority patent/US6458932B1/en
Priority to GR20000400586T priority patent/GR3032891T3/en
Priority to JP2004090279A priority patent/JP2004254695A/en
Priority to JP2005004934A priority patent/JP3907661B2/en
Publication of IL106591A publication Critical patent/IL106591A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention provides an interferon- alpha / beta binding protein, and also relates to its preparation and to pharmaceutical compositions comprising it.
IL106591A 1992-09-03 1993-08-04 Interferon alpha/beta binding protein, its preparation and pharmaceutical compositions containing it IL106591A (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
IL106591A IL106591A (en) 1992-09-03 1993-08-04 Interferon alpha/beta binding protein, its preparation and pharmaceutical compositions containing it
PT93114084T PT588177E (en) 1992-09-03 1993-09-02 ALPHA / BETA INTERFERENCE LIGACATION PROTEIN ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT
JP24398793A JP3662264B2 (en) 1992-09-03 1993-09-02 INTERFERON-α / β BINDING PROTEIN, PROCESS FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
AT93114084T ATE189262T1 (en) 1992-09-03 1993-09-02 INTERFERON ALPHA/BETA BINDING PROTEIN, ITS PREPARATION AND ITS CONTAINING PHARMACEUTICAL COMPOSITIONS
CA2105449A CA2105449C (en) 1992-09-03 1993-09-02 An interferon-.alpha./.beta. binding protein, its preparation and pharmaceutical compositions containing it
ES93114084T ES2142840T3 (en) 1992-09-03 1993-09-02 PROTEIN THAT JOINS THE ALPHA / BETA INTERFERON, ITS PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT.
DE69327693T DE69327693T2 (en) 1992-09-03 1993-09-02 Interferon-Alpha / Beta binding protein, its production and its containing pharmaceutical compositions
AU46096/93A AU674523B2 (en) 1992-09-03 1993-09-02 An interferon-alpha/beta binding protein its preparation and pharmaceutical compositions containing it
DK93114084T DK0588177T3 (en) 1992-09-03 1993-09-02 Interferon-alpha / beta-binding protein, preparation thereof and pharmaceutical preparations containing the protein
EP93114084A EP0588177B1 (en) 1992-09-03 1993-09-02 An interferon-alpha/beta binding protein, its preparation and pharmaceutical compositions containing it
US08/385,191 US5821078A (en) 1992-09-03 1995-02-07 Nucleic acid encoding interferon-α/β binding protein
US08/472,402 US6458932B1 (en) 1992-09-03 1995-06-07 Interferon-α/β binding protein, its preparation and use
GR20000400586T GR3032891T3 (en) 1992-09-03 2000-03-07 Signal transmission and tag power consumption measurement circuit for an inductive reader.
JP2004090279A JP2004254695A (en) 1992-09-03 2004-03-25 INTERFERON-alpha/beta BINDING PROTEIN, ITS PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
JP2005004934A JP3907661B2 (en) 1992-09-03 2005-01-12 INTERFERON-α / β BINDING PROTEIN, PROCESS FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL103052A IL103052A (en) 1992-09-03 1992-09-03 Soluble interferon-alpha receptors,their preparation and pharmaceutical compositions containing them
IL106591A IL106591A (en) 1992-09-03 1993-08-04 Interferon alpha/beta binding protein, its preparation and pharmaceutical compositions containing it

Publications (2)

Publication Number Publication Date
IL106591A0 true IL106591A0 (en) 1993-12-08
IL106591A IL106591A (en) 2008-03-20

Family

ID=26322502

Family Applications (1)

Application Number Title Priority Date Filing Date
IL106591A IL106591A (en) 1992-09-03 1993-08-04 Interferon alpha/beta binding protein, its preparation and pharmaceutical compositions containing it

Country Status (11)

Country Link
EP (1) EP0588177B1 (en)
JP (3) JP3662264B2 (en)
AT (1) ATE189262T1 (en)
AU (1) AU674523B2 (en)
CA (1) CA2105449C (en)
DE (1) DE69327693T2 (en)
DK (1) DK0588177T3 (en)
ES (1) ES2142840T3 (en)
GR (1) GR3032891T3 (en)
IL (1) IL106591A (en)
PT (1) PT588177E (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5821078A (en) * 1992-09-03 1998-10-13 Yeda Research And Development Co. Ltd. Nucleic acid encoding interferon-α/β binding protein
IL108584A (en) * 1994-02-07 2008-03-20 Yeda Res & Dev Cloning of interferon -alpha/beta binding protein
IL107378A (en) * 1993-10-24 2005-05-17 Yeda Res & Dev SOLUBLE INTERFERON alpha-RECEPTOR, ITS PREPARATION AND USE
IL118096A0 (en) * 1996-05-01 1996-09-12 Yeda Res & Dev Antibodies against interferon alpha/beta receptor
AU4070897A (en) * 1996-08-16 1998-03-06 Kurt B. Osther Method for treating diabetes
DE69731983T2 (en) * 1996-08-19 2005-10-06 Shaker, Ghassan I. USE OF MOLT4 CD69 EXPRESSION FOR DETERMINING THE PRESENCE AND ACTIVITY OF INTERFERONINHIBITORS
WO1999032141A1 (en) 1997-12-19 1999-07-01 Applied Research Systems Ars Holding N.V. Ifnar2/ifn complex
KR20080031022A (en) * 2005-06-22 2008-04-07 제넨테크, 인크. Methods and Compositions for Targeting IFNAR2

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL88377A (en) * 1988-11-14 1996-09-12 Yeda Res & Dev Cloning and expression of a protein which modulates cellular response to type I interferon
FR2657881A1 (en) * 1990-02-05 1991-08-09 Europ Biotechnologie Lab New water-soluble polypeptides, DNA sequences, new cells, process for preparation, applications and compositions containing the said polypeptides

Also Published As

Publication number Publication date
PT588177E (en) 2000-05-31
EP0588177A2 (en) 1994-03-23
JP3662264B2 (en) 2005-06-22
CA2105449A1 (en) 1994-03-04
DE69327693T2 (en) 2000-09-07
ATE189262T1 (en) 2000-02-15
JP2004254695A (en) 2004-09-16
JP2005162762A (en) 2005-06-23
EP0588177B1 (en) 2000-01-26
ES2142840T3 (en) 2000-05-01
DK0588177T3 (en) 2000-05-08
EP0588177A3 (en) 1994-08-17
DE69327693D1 (en) 2000-03-02
CA2105449C (en) 2010-07-20
IL106591A (en) 2008-03-20
AU674523B2 (en) 1997-01-02
JP3907661B2 (en) 2007-04-18
GR3032891T3 (en) 2000-07-31
AU4609693A (en) 1994-03-10
JPH06220100A (en) 1994-08-09

Similar Documents

Publication Publication Date Title
IL74365A (en) 17beta-(n-t.-butylcarbamoyl)-4-aza-5alpha-androst-1-en-3-one and pharmaceutical compositions containing it
IL103612A0 (en) Peptides,their preparation and pharmaceutical compositions containing them
IL85609A0 (en) Phenyl carbamate,its preparation and pharmaceutical compositions containing it
ZA911279B (en) Novel protein compositions
IL92937A0 (en) Human derived monocyte attracting protein,pharmaceutical compositions comprising it and dna encoding it
IL81800A0 (en) 1,2,3,4-tetrahydro-6-substituted-4-aryl(or heterocyclo)-3-((substituted amino)carbonyl)-2-thioxo(or oxo)-5-pyrimidine-carboxylic acids and esters and pharmaceutical compositions containing the same
IL67978A0 (en) Human immune interferon,its preparation and purification and pharmaceutical compositions containing it
IL88404A0 (en) Neutrophil activating factor,its preparation and pharmaceutical compositions containing it
EP0655752A3 (en) Ceramic composition and thermistor comprising such ceramic compositon.
IL106591A0 (en) An interferon alpha/beta binding protein,its preparation and pharmaceutical compositions containing it
NZ221374A (en) Recombinant interferon and compositions containing it
EP0620860A4 (en) Preparation of recombinant borrelia proteins.
IL76956A (en) Antibiotic polypeptide,its preparation and pharmaceutical compositions containing it
IL83594A0 (en) Human low affinity fce-receptor,its isolation,its recombinant preparation and pharmaceutical compositions containing it
IL88743A0 (en) Soluble recombinant fcepsilon-receptor,its preparation and pharmaceutical compositions containing it
IL95312A0 (en) Substituted pyrazine,its preparation and pharmaceutical compositions containing it
ZA921416B (en) Pharmaceutical compositions comprising interleukin-2
IL88673A0 (en) N-hydroxy-5-phenyl-2-furancarboxi-midamides,and pharmaceutical compositions containing them
EP0275207A3 (en) Pharmaceutical, veterinary and cosmetic compositions and uses
GB2206115B (en) 8a-acylaminoergoline, its preparation and pharmaceutical compositions containing it
IL85239A0 (en) Recombinant alveolar surfactant protein,its production and purification and pharmaceutical compositions containing it
IL82780A0 (en) Peptides,their manufacture and pharmaceutical compositions containing them
NZ242293A (en) Recombinant poliovirus and pharmaceutical compositions containing it
ZA88286B (en) Pharmaceutical,veterinary and cosmetic compositions and uses
IL94658A0 (en) 1,5-diazabicyclodiones and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
KB Patent renewed
EXP Patent expired